Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)

China flag China · Delayed Price · Currency is CNY
12.61
+0.11 (0.88%)
Jul 29, 2026, 3:04 PM CST
Market Cap5.27B -27.4%
Revenue (ttm)800.05M +1.9%
Net Income57.52M -25.0%
EPS0.14 -25.0%
Shares Out 417.60M
PE Ratio91.52
Forward PEn/a
Dividend0.08 (0.60%)
Ex-Dividend DateJun 4, 2026
Volume3,814,000
Open12.50
Previous Close12.50
Day's Range12.32 - 12.70
52-Week Range11.42 - 21.52
Beta-0.17
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About SHE:002907

Chongqing Pharscin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China and internationally. It offers generic drugs, traditional Chinese medicines, and food for special medical purposes in various forms, including tablets, granules, capsules, soft capsules, powders, powder injections, lyophilized powder injections, small-volume injections, chemical raw materials, and traditional Chinese medicine extracts. The company is also involved in the provision of CDMO and ... [Read more]

Sector Healthcare
Founded 1996
Employees 1,439
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002907
Full Company Profile

Financial Performance

In 2025, SHE:002907's revenue was 827.14 million, an increase of 6.75% compared to the previous year's 774.82 million. Earnings were 65.09 million, a decrease of -15.17%.

Financial Statements